Alzinova AB (publ) (STO:ALZ)
Sweden · Delayed Price · Currency is SEK 0.9750
-0.0270 (-2.69%)
Aug 14, 2026, 5:29 PM CET
Alzinova AB Market Cap
Alzinova AB has a market cap or net worth of 197.57 million as of August 14, 2026. Its market cap has increased by 59.95% in one year.
Market Cap
197.57M
Enterprise Value
186.99M
Revenue
25.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
ChartMarket Cap Chart
Since November 25, 2015, Alzinova AB's market cap has increased from 57.35M to 197.57M, an increase of 244.51%. That is a compound annual growth rate of 12.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 197.57M | 128.45% |
| Dec 30, 2025 | 86.48M | -71.97% |
| Dec 30, 2024 | 308.51M | 128.27% |
| Dec 29, 2023 | 135.15M | 50.50% |
| Dec 30, 2022 | 89.80M | -11.61% |
| Dec 30, 2021 | 101.60M | -13.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 281.39M |
| IRLAB Therapeutics AB | 240.91M |
| Xbrane Biopharma AB | 200.70M |
| Elicera Therapeutics AB | 196.54M |
| Abera Bioscience AB | 172.19M |
| Initiator Pharma | 170.45M |
| Xintela AB | 160.20M |
| Diamyd Medical AB | 158.08M |